Skip to main content
. 2021 Jan 19;7(1):e20236. doi: 10.2196/20236

Table 3.

Changes in COVID-19 symptoms before and after accessing the Korean Medicine telemedicine program.

COVID-19 symptoms and severity At first call, n (%) At last call, n (%) P valuea
Headache <.001

Severe 3 (0.1) 0 (0.0) N/Ab

Moderate 49 (2.4) 3 (0.2) N/A

Mild 361 (17.4) 112 (9.3) N/A

None 1658 (80.1) 1092 (90.5) N/A

Total 2071 (100.0) 1207 (100.0) N/A
Chills <.001

Severe 2 (0.1) 0 (0.0) N/A

Moderate 11 (0.5) 0 (0.0) N/A

Mild 207 (10.0) 57 (4.7) N/A

None 1843 (89.3) 1158 (95.3) N/A

Total 2063 (100.0) 1215 (100.0) N/A
Sputum <.001

Severe 12 (0.6) 2 (0.2) N/A

Moderate 43 (2.0) 10 (0.8) N/A

Mild 707 (33.4) 308 (24.0) N/A

None 1357 (64.0) 963 (75.1) N/A

Total 2119 (100.0) 1283 (100.0) N/A
Dry cough <.001

Severe 3 (0.1) 0 (0.0) N/A

Moderate 116 (5.5) 16 (1.3) N/A

Mild 640 (30.6) 233 (18.7) N/A

None 1335 (63.8) 994 (80.0) N/A

Total 2094 (100.0) 1243 (100.0) N/A
Sore throat <.001

Severe 2 (0.1) 0 (0.0) N/A

Moderate 43 (2.1) 2 (0.2) N/A

Mild 355 (17.0) 117 (9.5) N/A

None 1684 (80.8) 1113 (90.3) N/A

Total 2084 (100.0) 1232 (100.0) N/A
Fatigue <.001

Severe 15 (0.7) 3 (0.2) N/A

Moderate 164 (8.1) 27 (2.2) N/A

Mild 616 (30.5) 325 (26.7) N/A

None 1223 (60.6) 860 (70.8) N/A

Total 2018 (100.0) 1215 (100.0) N/A
Muscle pain <.001

Severe 7 (0.3) 0 (0.0) N/A

Moderate 60 (2.9) 8 (0.7) N/A

Mild 334 (16.2) 108 (9.1) N/A

None 1661 (80.6) 1066 (90.2) N/A

Total 2062 (100.0) 1182 (100.0) N/A
Rhinorrhea <.001

Severe 9 (0.4) 0 (0.0) N/A

Moderate 43 (2.1) 4 (0.3) N/A

Mild 316 (15.3) 164 (13.6) N/A

None 1694 (82.2) 1042 (86.1) N/A

Total 2062 (100.0) 1210 (100.0) N/A
Nasal congestion <.001

Severe 5 (0.2) 1 (0.1) N/A

Moderate 42 (2.0) 4 (0.3) N/A

Mild 386 (18.7) 118 (9.8) N/A

None 1627 (79.0) 1078 (89.8) N/A

Total 2060 (100.0) 1201 (100.0) N/A
Dyspnea <.001

Severe 17 (0.9) 0 (0.0) N/A

Moderate 36 (1.9) 8 (0.7) N/A

Mild 413 (21.7) 137 (12.8) N/A

None 1439 (75.5) 924 (86.4) N/A

Total 1905 (100.0) 1069 (100.0) N/A
Chest tightness <.001

Severe 0 (0.0) 0 (0.0) N/A

Moderate 51 (2.5) 4 (0.3) N/A

Mild 142 (7.0) 29 (2.5) N/A

None 1844 (90.5) 1144 (97.2) N/A

Total 2037 (100.0) 1171 (100.0) N/A
Diarrhea <.001

Severe 6 (0.3) 1 (0.1) N/A

Moderate 13 (0.6) 0 (0.0) N/A

Mild 181 (8.8) 87 (7.4) N/A

None 1853 (90.3) 1095 (92.6) N/A

Total 2053 (100.0) 1183 (100.0) N/A
Loss of appetite <.001

Severe 10 (0.5) 2 (0.2) N/A

Moderate 134 (6.7) 25 (2.1) N/A

Mild 449 (22.5) 154 (12.9) N/A

None 1407 (70.4) 1009 (84.8) N/A

Total 2000 (100.0) 1190 (100.0) N/A

aThe Wilcoxon signed-rank test was performed.

bN/A: not applicable.